JPMorgan SMid Cap Biotech Analyst Rama, along with CEO MCCarthy, participate in a conference call to be held on April 10 at 1 pm. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CTMX:
- CytomX Therapeutics participates in a conference call with JPMorgan
- CytomX Therapeutics price target lowered to $2 from $4 at Mizuho
- CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
- CytomX Therapeutics Inc. (CTMX) Q4 Earnings Cheat Sheet
- CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023